Administrative Core
行政核心
基本信息
- 批准号:10401456
- 负责人:
- 金额:$ 26.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-16 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAchievementAcuteAddressAdministrative CoordinationAdministratorAdvanced DevelopmentAdvisory CommitteesBiologicalBiometryBudgetsCell LineChemicalsCollaborationsCommunicationControl GroupsDataDevelopmentEnsureEvaluationFosteringGoalsGovernmentHuman ResourcesIndividualIndustryInfrastructureIntellectual PropertyLeadershipMarylandMeasuresMedical centerModelingMonitorNational Institute of Allergy and Infectious DiseaseOrganization and AdministrationPeer ReviewPerformancePreparationProceduresProductivityPublicationsRadiationRadiation PhysicsRadiation SyndromesRandomizedReagentReportingResearchResearch Project GrantsResource AllocationResource SharingResourcesScienceServicesSiteStrategic PlanningStrategic visionStructureSystemTestingTimeTraining and EducationTravelUnited States National Institutes of HealthUniversitiesbasecareerconflict resolutioncost effectivedata sharingdosimetryexperimental studyinterestmedical countermeasuremeetingsmemberoperationprogramsradiation countermeasuresexsoundstudent trainingsuccesssymposiumsynergismweb site
项目摘要
PROJECT SUMMARY/ABSTRACT - CORE A: ADMINISTRATIVE CORE
!
The Administrative Core will provide cost-effective and centralized organization, administration, coordination,
monitoring, support, and management of the INTERACT Consortium as a member of the larger CMCRC to
facilitate achievement of the overall goals of the Consortium. This Core will provide administrative and
managerial oversight, effective and proactive leadership, and emphasize INTERACTions among Project and
Core Leads to support the development of medical countermeasures (MCM). Core A will ensure scientific rigor
through radiation physics/dosimetry support and biostatistical oversight. Core A will also provide oversight of
authentication plans, ensure appropriate randomization, blinding, and control groups, and minimize biological
variability by requiring use of both sexes in all experimental studies. Core A will also encourage new opportunities
for research collaborations as well as education and training of students and early career professionals interested
in the radiation sciences and MCMs. Core A is supported by a full-time project manager, a program administrator,
and an accountant. The Core also includes an External Scientific Advisory Group (ESAG) comprised of industry,
regulatory, and scientific experts. To measure success and monitor progress, the Administrative Core will hold
a monthly meeting with all Project Leads and Core Directors, a biannual strategic review of operations, and an
Annual Research Retreat. Ad hoc meetings will be held as needed. Tactical evaluations will take place biannually
to ensure projects remain in scope, on time, and on budget. Core A will provide sound fiscal management to
ensure best value to the government. Core A will coordinate closely with the Coordinating Center Core to ensure
that all data is shared with program officers at NIAID/NIH, the program-wide CMCRC, and the field in general as
rapidly as possible.
!
项目概要/摘要 - 核心 A:行政核心
!
行政核心将提供具有成本效益的集中组织、管理、协调、
作为更大的 CMCRC 成员,对 INTERACT 联盟进行监控、支持和管理,
促进联盟总体目标的实现。该核心将提供行政和
管理监督、有效和主动的领导,并强调项目和项目之间的互动
核心线索支持医疗对策 (MCM) 的发展。核心A将确保科学严谨性
通过辐射物理/剂量测定支持和生物统计监督。核心 A 还将监督
验证计划,确保适当的随机化、盲法和对照组,并最大限度地减少生物
由于在所有实验研究中都需要使用两种性别,因此存在变异性。核心A也将鼓励新的机会
用于研究合作以及对感兴趣的学生和早期职业专业人员的教育和培训
辐射科学和 MCM。核心 A 由一名全职项目经理、一名项目管理员提供支持,
和一名会计师。该核心还包括一个外部科学咨询小组 (ESAG),由行业、
监管和科学专家。为了衡量成功和监测进展,行政核心将举行
每月与所有项目负责人和核心董事举行会议,每两年进行一次运营战略审查,以及
年度研究务虚会。根据需要召开临时会议。战术评估将每两年进行一次
确保项目保持在范围内、按时、按预算进行。核心A将提供健全的财务管理
确保为政府带来最大价值。核心 A 将与协调中心核心密切协调,以确保
所有数据均与 NIAID/NIH 的项目官员、整个项目的 CMCRC 以及整个领域共享
尽快。
!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Isabel Lauren Jackson其他文献
Isabel Lauren Jackson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Isabel Lauren Jackson', 18)}}的其他基金
Animal Efficacy and Pharmacometric Modeling Core
动物功效和药理学建模核心
- 批准号:
10401458 - 财政年份:2020
- 资助金额:
$ 26.33万 - 项目类别:
Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes
相互协作辐射对策 (INTERACT) 联盟,促进减轻/治疗急性和迟发性辐射综合症的医疗对策高级发展
- 批准号:
10194363 - 财政年份:2020
- 资助金额:
$ 26.33万 - 项目类别:
Development of BIO 300 for mitigation and/or treatment of radiation pneumonitis and fibrosis
开发用于缓解和/或治疗放射性肺炎和纤维化的 BIO 300
- 批准号:
10845829 - 财政年份:2020
- 资助金额:
$ 26.33万 - 项目类别:
Animal Efficacy and Pharmacometric Modeling Core
动物功效和药理学建模核心
- 批准号:
10845825 - 财政年份:2020
- 资助金额:
$ 26.33万 - 项目类别:
Animal Efficacy and Pharmacometric Modeling Core
动物功效和药理学建模核心
- 批准号:
10194366 - 财政年份:2020
- 资助金额:
$ 26.33万 - 项目类别:
Development of BIO 300 for mitigation and/or treatment of radiation pneumonitis and fibrosis
开发用于缓解和/或治疗放射性肺炎和纤维化的 BIO 300
- 批准号:
10194370 - 财政年份:2020
- 资助金额:
$ 26.33万 - 项目类别:
Development of BIO 300 for mitigation and/or treatment of radiation pneumonitis and fibrosis
开发用于缓解和/或治疗放射性肺炎和纤维化的 BIO 300
- 批准号:
10401463 - 财政年份:2020
- 资助金额:
$ 26.33万 - 项目类别:
Development of BIO 300 as a MCM for lethal radiation pneumonitis/fibrosis
开发 BIO 300 作为致命放射性肺炎/纤维化的 MCM
- 批准号:
9201938 - 财政年份:2016
- 资助金额:
$ 26.33万 - 项目类别:
相似国自然基金
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
成就目标视角下建言韧性的形成机制与作用效果研究
- 批准号:72102228
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
科研人员流动与职业成就的关系研究
- 批准号:71874049
- 批准年份:2018
- 资助金额:48.0 万元
- 项目类别:面上项目
基于目标成就评量的社区中医药健康管理服务评价及优化策略研究
- 批准号:71874047
- 批准年份:2018
- 资助金额:49.0 万元
- 项目类别:面上项目
相似海外基金
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
- 批准号:
10569397 - 财政年份:2023
- 资助金额:
$ 26.33万 - 项目类别:
Clinical and Molecular based prognostic factors for Venous Thromboembolism (VTE) in Children with Sickle Cell Disease
镰状细胞病儿童静脉血栓栓塞 (VTE) 的临床和分子预后因素
- 批准号:
10739524 - 财政年份:2023
- 资助金额:
$ 26.33万 - 项目类别:
Estimating the population size of persons who inject drugs in New York
估计纽约注射吸毒者的人口规模
- 批准号:
10705455 - 财政年份:2022
- 资助金额:
$ 26.33万 - 项目类别:
Increasing representation of black communities in SARS-CoV-2 serosurveys by understanding barriers and motivations for participation
通过了解参与的障碍和动机,增加黑人社区在 SARS-CoV-2 血清调查中的代表性
- 批准号:
10843497 - 财政年份:2021
- 资助金额:
$ 26.33万 - 项目类别:
Improving Risk-Stratification in Patients with Prolonged ICU Stays
改善长期入住 ICU 患者的风险分层
- 批准号:
10184329 - 财政年份:2021
- 资助金额:
$ 26.33万 - 项目类别: